Diffuse intrinsic pontine gliomas (DIPGs) carry an extremely poor prognosis. Standard practice has been to base the diagnosis on classic imaging and clinical characteristics and to treat with focal ...

Reese Wireman was diagnosed with Diffuse Intrinsic Pontine Glioma the weekend after Thanksgiving.

Please provide your email address to receive an email when new articles are posted on . The single-center, dose-escalation study included 12 patients (median age, 9 years; 58% female) with newly ...

Diffuse intrinsic pontine gliomas (DIPGs), with a median survival of 9 months, represent the biggest therapeutic challenge in pediatric neuro-oncology. Despite many clinical trials, no major ...

Like other tumors that arise in midline structures of the brain, most DIPGs are histone H3-mutated tumors that harbor H3K27M mutations. DIPG typically originates in the ventral pons, which is the ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified clinical, radiologic and molecular factors associated with survival among children and ...

Oblato plans to evaluate OKN-007 for diffuse intrinsic pontine glioma in a phase 1/2 trial this year. The Food and Drug Administration (FDA) has fast tracked an investigational therapy for diffuse ...

Diffuse intrinsic pontine glioma (DIPG) is an almost universally fatal brain pediatric tumor and the only tumor indication where palliative radiotherapy is the current standard of care. Although ...

HOUSTON, Texas (KTRK) -- Six months ago, we told you about a young woman who was diagnosed with a deadly brain tumor only found in children. She has been on a journey with Houston Methodist Hospital ...